Company Filing History:
Years Active: 2025
Title: Hubert Schrezenmeier: Innovator in Complement Inhibition
Introduction
Hubert Schrezenmeier is a notable inventor based in Ulm, Germany. He has made significant contributions to the field of biomedicine, particularly in the area of complement inhibitors. His work focuses on developing innovative solutions for treating diseases associated with inappropriate complement activation.
Latest Patents
Schrezenmeier holds a patent for "Complement inhibitors and uses thereof." This invention involves a multi-domain polypeptide that includes a complement control protein repeat (CCP)-comprising domain, a host cell recognition domain, and a second CCP-comprising domain with cofactor activity. The invention also encompasses a polynucleotide encoding the multi-domain polypeptide, a vector containing this polynucleotide, and a host cell that includes the polynucleotide and/or vector. The applications of this invention are significant in medicine, particularly for treating and preventing diseases characterized by inappropriate complement activation.
Career Highlights
Throughout his career, Hubert Schrezenmeier has been associated with prestigious institutions such as Universität Ulm. His research and innovations have contributed to advancements in medical science, particularly in understanding and manipulating the complement system.
Collaborations
Schrezenmeier has collaborated with notable colleagues, including Christoph Schmidt and Markus Anliker. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.
Conclusion
Hubert Schrezenmeier's work in developing complement inhibitors showcases his commitment to advancing medical science. His innovative approaches and collaborations have the potential to significantly impact the treatment of diseases related to complement activation.